A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...

Ongoing research is needed to fully understand their risks, especially for long-term and higher-dose users. However, many ...

A New Zealand bariatric surgeon cautions that Wegovy, a new weight-loss drug, isn't a magic bullet for obesity. While it can trigger initial weight loss, long-term success hinges on lifestyle changes ...

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

As the popularity of medications for weight loss, such as Ozempic and Wegovy, surges across North America, new research ...

Wegovy® is indicated for chronic weight management in adults and adolescents (12+) with obesity or overweight and at least ...

Some weight loss drugs may cause hair loss. While it’s typically a temporary side effect, it can affect your confidence.

When Amy Schumer realized Ozempic and Wegovy had harmful side effects for her, she didn’t let that deter her from trying other prescriptions to lose ...

A recent survey highlighted a widespread lack of understanding about the much-publicised GLP-1 weight-loss medications ...

The move follows a dramatic breakup in June between Hims & Hers and Danish drug maker Novo Nordisk, which makes the brand name weight loss drug Wegovy. Novo Nordisk accused the Hims & Hers of ...